FourThought Financial’s AstraZeneca AZN Stock Holding History

FourThought Financial’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3.48M	Sell	31,696 -53	-0.2%	-$6.72K	0.51%	49
2022 Q2	$4.2M	Sell	31,749 -304	-0.9%	-$39.9K	0.61%	43
2022 Q1	$4.26M	Buy	32,053 +5,149	+19%	+$617K	0.54%	49
2021 Q4	$3.13M	Buy	26,904 +2,498	+10%	+$294K	0.39%	60
2021 Q3	$2.93M	Buy	24,406 +24,142	+9,145%	+$2.81M	0.39%	65
2021 Q2	$31K	Hold	264	–	–	﹤0.01%	839
2021 Q1	$26K	Sell	264 -15	-5%	-$1.51K	﹤0.01%	840
2020 Q4	$27K	Buy	+279	New	+$29.6K	﹤0.01%	805

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

FourThought Financial's AZN Position: Q3 2022 in Review

FourThought Financial reduced its AstraZeneca (AZN) stake by 0.17% in Q3 2022, selling an estimated $6.72K and leaving 31,696 shares worth $3.48M. The position accounts for 0.51% of the portfolio, ranked #49.

FourThought Financial first reported a position in AZN in Q4 2020 and has held it in 8 quarters since. The position peaked at $4.26M in Q1 2022. 966 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

FourThought Financial held 31,696 shares of AstraZeneca worth $3.48M as of Q3 2022.
FourThought Financial sold 53 AstraZeneca shares in Q3 2022, an estimated $6.72K.
AstraZeneca made up 0.51% of FourThought Financial's portfolio in Q3 2022, its #49 holding.
FourThought Financial first reported a position in AstraZeneca in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's AstraZeneca position peaked at $4.26M in Q1 2022.
966 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.